Remy Durand is Chief Business Officer of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 0 shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on May 20, 2024, when has been sold 133,392 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

REMY DURAND Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Sale (or disposition) back to the issuer
-
133,392 Reduced 100.0%
0 Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
$606,031 $6.36 p/Share
95,288 Added 41.67%
133,392 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
31,200 Added 45.02%
38,104 Common Stock
RD

Remy Durand

Chief Business Officer
Seattle, WA

Track Institutional and Insider Activities on ALPN

Follow ALPINE IMMUNE SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN